读取中,请稍候

00-00 00:00:00
--.--
0.00 (0.000%)
昨收盘:0.000今开盘:0.000最高价:0.000最低价:0.000
成交额:0成交量:0买入价:0.000卖出价:0.000
市盈率:0.000收益率:0.00052周最高:0.00052周最低:0.000
百济神州:港股公告:百济神州有限公司截至2024年3月31日止三个月未经审核业绩以及业务进展最新情况 下载公告
公告日期:2024-05-09

BeiGene, Ltd.

06160

2024331

13.09

571XIVA

2024331

20243312024

202458

1995(Private Securities LitigationReform Act of 1995)

10-Q

202458

Olivier BrandicourtMargaret Han DuganDonald W. GlazerMichael GollerAnthony C. HooperRanjeev KrishanaAlessandro RivaCorazon (Corsee) D. Sanders

2024? 7.527.4782%?

?

4.89

153%243%FDA

?

BTK? sonrotoclax

?BTK CDAC? ADC

?BGNE

061606882352024

(John V. Oyler)?

?

BTK

?

20242023(%)$ 746,918$ 410,29182%$ 4,734$ 37,510(87)%$ 751,652$ 447,80168%GAAP$ (261,348)$ (371,258)(30)%

*$ (147,341)$ (275,859)(47)%

* GAAP(GAAP)

GAAPGAAP

?

? 2024

?

3.51153%(TN)(CLL)(R/R)CLLBTK2024

?

6,700243%

?CLL(WM)

? 3ALPINE3ASCEND

?

R/R CLL

?(CR)? (FDA)CD20

R/R

?? 2024

?

1.4526%? (NSCLC)

? FDA(ESCC)? (BLA)FDA

?

?

ESCCFDA(PDUFA)FDA

20247

SonrotoclaxBCL-2

? FDAR/R(MCL)? R/R MCLWM

?

TN CLL3850

BGB-16673(BTK CDAC)

? R/R MCLR/R CLL

? 2024R/R CLL3

? TIGITPD-L1NSCLC3

? BGB-A445OX40LBL-007LAG-3

BGB-15025HPK12024

? KRASMTAPRMT5EGFR CDAC2024

?BGB-43395CDK4

?BG-68501CDK2:

?BG-C9074 (B7H4 ADC)

? 2024LBL-007LAG-3BGB-A445OX40

? (NMPA)

? CEA-ADCFGFR2b-ADC2024

? (USPTO)Pharmacyclics

USPTO12

? 2023

?

2024

20243317.522023

4.48

?

153%243%

20243317.472023

4.1082%

??

2024331

3.511.39202483%80%

?

GAAPGAAP20242023

(%)

20242023

(%)$ 460,638$ 408,58413%$ 405,440$ 361,69612%$ 427,427$ 328,49930%$ 372,146$ 283,15431%$ –$ 187(100)%$ –$ –$ 888,065$ 737,27020%$ 777,586$ 644,85021%2024GAAP2024

3,500

(SG&A)2024GAAPSG&A

?

2024SG&A57%80%2024GAAP30%

47%

GAAP2024331GAAP

20243310.19(ADS)2.410.26ADS3.34

2024331

3.095.64

2024

202410-Q

10,000www.beigene.com.cn

1995(Private Securities LitigationReform Act of 1995)

10-Q

(+86 10) 5895-8058(+86 21) 3159-1070ir@beigene.com media@beigene.com

ADSADS

20242023

$ 746,918$ 410,291

4,73437,510 751,652447,801

124,93581,789626,717366,012460,638408,584427,427328,499

–187 888,065737,270

(261,348)(371,258)

16,16016,016

1,76218,303(243,426)(336,939)

7,72411,492(251,150)(348,431)$ (0.19)$ (0.26)1,355,547,6261,354,164,760ADS$ (2.41)$ (3.34)

ADS104,272,894104,166,520

GAAP

202420233311231

$ 2,807,436$ 3,188,584435,294358,027447,345416,1221,417,9921,324,1545,667,6815,805,275

356,575315,111569,438693,731225,530238,6661,025,992885,9842,307,3202,267,948$ 3,360,361$ 3,537,327(GAAP)GAAPGAAPGAAPGAAPGAAP

GAAPGAAP

GAAP

GAAPGAAP

GAAPGAAP

GAAPGAAPGAAP

GAAPGAAP

GAAPGAAP

20242023GAAPGAAP$ 124,935$ 81,789

2,3452,1801,183799$ 121,407$ 78,810GAAPGAAP$ 460,638$ 408,584

38,04534,02817,15312,860$ 405,440$ 361,696GAAPGAAP$ 427,427$ 328,499

50,66941,360

4,6123,985$ 372,146$ 283,154GAAPGAAP$ 888,065$ 737,270

88,71475,38821,76516,845

–187$ 777,586$ 644,850GAAPGAAP$ (261,348)$ (371,258)

88,71475,38824,11019,025

1,183986$ (147,341)$ (275,859)


  附件:公告原文
返回页顶